Therapeutic Category
Gastrointestinal
UPRATOP
Pantoprazole & Domperidone for the management of acid reflux and impaired gastrointestinal motility.
Gastrointestinal Brand
UPRATOP
UPRATOP Capsules contains pantoprazole and domperidone for the treatment of acid-related gastrointestinal conditions
Dosage Form
Capsules
Strength Available
40mg + 30mg
Pack size
Pack of 3x10 Capsules
Therapeutic Indications
- Gastroesophageal reflux disease (GERD)
- Gastric and duodenal ulcers
- Helicobacter Pylori infection in combination with two antibiotics
- Dyspepsia and conditions requiring acid suppression
- Zollinger-Ellison syndrome
Brand Name
UPRATOP
Product Name
UPRATOP
Generic Name
Pantoprazole sodium and Domperidone Capsules 40mg/30mg
Dosage Form
Capsules
Pack Size
Pack of 3x10 Tablets
Therapeutic Indication
- For the treatment of acid-related gastrointestinal conditions associated with impaired upper gastrointestinal motility
Dosage and Method of Administration
Adults:
- Oesophageal reflux : 1 capsule once daily for 4–8 weeks
- Gastric or duodenal ulcers : 1 capsule once daily for 4–8 weeks
- Zollinger–Ellison syndrome : Initially, 2 capsules daily adjusted according to clinical response
- H. pylori associated duodenal ulcer : 1 capsule twice daily for 7–14 days in combination with appropriate antibiotics
Children:
Use only when prescribed by a physician
Mode of Administration
For oral use only